| Outcome Measures: |
Primary: Change in HbA1c level, Change in HbA1c (From baseline to 12 weeks), The participants will be assessed before initiation of the study (baseline), and at the end of the study after 3 months.|Change in body weight., Change in body weight (From baseline to 12 weeks)., The participants will be assessed before initiation of the study (baseline), and at the end of the study after 3 months.|Change in Body mass index (BMI), Change in Body mass index (BMI) (From baseline to 12 weeks)., The participants will be assessed before initiation of the study (baseline), and at the end of the study after 3 months.|Change in Visceral adiposity index (VAI)., Change in Visceral adiposity index (VAI) (From baseline to 12 weeks)., The participants will be assessed before initiation of the study (baseline), and at the end of the study after 3 months. | Secondary: Change in Adiponenctin, Interleukin-6 (IL-6) and Nitric oxide (NO) serum levels., Assessment of Adiponenctin, Interleukin-6 (IL-6) and Nitric oxide levels by ELISA Kits according to manufacturer's instructions., The participants will be assessed before initiation of the study (baseline), and at the end of the study after 3 months.
|
